Marijuana MSOs report mixed financial results after tough year

Apr 26, 2023 · Cash flow from operations was $159 million, and the company reported a net income of $12 million. Massachusetts-based MariMed grew revenue to $134 million in 2022 …

$159
OFF

Marijuana MSOs Report Mixed Financial Results After Tough Year

1 week from now

Apr 26, 2023 · Cash flow from operations was $159 million, and the company reported a net income of $12 million. Massachusetts-based MariMed grew revenue to $134 million in 2022 …

mjbizdaily.com

$40
OFF

Marijuana MSOs Post Strong Quarterly Results, But Investors Tepid

1 week from now

Sep 13, 2021 · Four of the largest five publicly held MSOs actually made a profit in the quarter, with Florida-based Trulieve Cannabis leading the way with $40.9 million in earnings. …

mjbizdaily.com

26%
OFF

What's In The Cards For Cannabis MSOs In Q3? Analyst's …

1 week from now

Nov 4, 2021 · Considering that the MSOs ETF is down 26% over the last three month period and 51% off the 2/10 peak, “the group is looking for a positive catalyst,” Zuanic said, adding that the third-quarter ...

businessinsider.com

2%
OFF

Top Marijuana MSOs Amid Earnings Season: Analyst Shares Key …

1 week from now

Nov 29, 2022 · Top Marijuana MSOs Amid Earnings Season: Analyst Shares Key Takeaways From Q3 Reports & What They Mean ... Even though the company reported a 2% year-over …

businessinsider.com

00%
OFF

AdvisorShares Pure US Cannabis ETF (MSOS) - Yahoo Finance

1 week from now

Net Assets 860.56M. NAV 4.97. PE Ratio (TTM) --. Yield 0.00%. YTD Daily Total Return -25.53%. Beta (5Y Monthly) 1.51. Expense Ratio (net) 0.83%. AdvisorShares Pure US Cannabis ETF …

yahoo.com

4%
OFF

Just 24.4% Of U.S. Cannabis Operators Profitable, Study Finds

1 week from now

Jun 23, 2023 · Last year’s Cannabis Operator Sentiment and Business Conditions survey report found that 42% of marijuana businesses were turning a profit, according to a news release. ...

mjbizdaily.com

$75
OFF

Marijuana Investing: The Pros And Cons Of MSOs - Kiplinger

1 week from now

Sep 22, 2021 · A private, single-state cannabis company is an acquisition target for an MSO (like the recent acquisitions of Blue Camo for more than $75 million, HMS Health for $27.5 million, …

kiplinger.com

FAQs about Marijuana MSOs report mixed financial results after tough year Coupon?

Is a private cannabis company a target for an MSO?

A private, single-state cannabis company is an acquisition target for an MSO (like the recent acquisitions of Blue Camo for more than $75 million, HMS Health for $27.5 million, and Dharma Pharmaceuticals for $80 million). ...

Is MSOs a diversified fund?

It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The fund is non-diversified. MSOS - AdvisorShares Pure US Cannabis ETF - Stock screener for investors and traders, financial visualizations. ...

Should you invest in a cannabis exchange-traded fund (ETF)?

For investors that want to diversify, it's also worth looking at cannabis exchange-traded funds (ETFs). The AdvisorShares Pure US Cannabis ETF ( MSOS ), for instance, holds a number of well-known MSO stocks (hence the ticker). ...

Which MSO stocks are publicly traded in Canada?

Several MSO stocks – such as Curaleaf ( CURLF ), Trulieve ( TCNNF) and Green Thumb Industries ( GTBIF) – are traded publicly. Because cannabis is still illegal on the federal level in the U.S., several of these companies can be found on Canadian stock boards and may require investors to use a special brokerage account to purchase. ...

Are cannabis companies worth more?

Eleven out of these fourteen companies have seen their valuation multiples rise, with increases ranging from 3% to a remarkable 70%. As a group, these cannabis companies have seen their overall market value rise by 39%, indicating they're now valued higher compared to their future profits. ...

Should you invest in the cannabis industry?

According to Viridian, companies showing modest valuation multiples but increasing EBITDA expectations, like Ascend Wellness Holdings, Inc. (OTC:AAWH) and Cresco, may offer intriguing investment opportunities amidst the dynamic valuation landscape in the cannabis industry. ...